Caracteristica cazurilor cu recidivă de tuberculoză pulmonare

Kulciţchi Stela; Vîlc Valentina; Malic Alina; Demişcan Galina

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

883

Ultima descărcare din IBN:
2018-10-08 19:26

SM ISO690:2012

KULCIŢCHI, Stela, VÎLC, Valentina, MALIC, Alina, DEMIŞCAN, Galina. Caracteristica cazurilor cu recidivă de tuberculoză pulmonare. In: Analele Ştiinţifice ale USMF „N. Testemiţanu”, 2013, nr. 3(14), pp. 391-395. ISSN 1857-1719.

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Analele Ştiinţifice ale USMF „N. Testemiţanu”

Numărul 3(14) / 2013 / ISSN 1857-1719

Caracteristica cazurilor cu recidivă de tuberculoză pulmonare

Pag. 391-395

Kulciţchi Stela¹, Vîlc Valentina¹, Malic Alina¹, Demişcan Galina²

¹ Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“,
² IMSP Institutul de Ftiziopneumologie „Chiril Draganiuc“

Disponibil în IBN: 23 ianuarie 2014

Descarcă PDF

Rezumat

In stuidu au fost incluse 417 cazuri de recidivă a tuberculozei pulmonare, aflaţi la tratament în Spitalul Clinic Municipal de Ftiziopneumologie Chisinau în anii 2010-2012. În structura incidenței globale recidivele de TB pulmonară au constituit 21,5 la 100 000 populaţie în anul 2012 sau cu 4,6% mai mult decît in anul 2011. A predominat depistarea pasivă - 357(86%) cazuri. Printre formele clinice de TB predomină TB pulmonară infiltrativă - 254(51%). Factori cu risc sporit pentru îmbolnăvire au avut un impact decisiv în aparitia recidivelor, 213 (51%) bolnavi au fost din grupul de risc. Aproximativ 1/2 din bolnavii cu recidive de TB pulmonară au fost sensibili la preparatele antituberculoase de prima linie (40%), în 25 % cazuri a fost stabilită Multidrogrezistența.

In study have been included 417 cases of relapse of pulmonary tuberculosis, who were treated in clinical municipal hospital from Chisinau in 2010-2012. In the structure of the global incidence of pulmonary TB recurrences were 21.5 to 100 000 people in 2012, with 4.6% more than in 2011. The passive way of detection have been predominated - 357 (86%) cases. Among clinical forms of TB infiltrative pulmonary TB have been predominated - 254 (51%). Risk factors for the disease have had a decisive impact in the occurrence of relapses, 213 (51%) patients were with risk factors. About half of patients with relapses of pulmonary TB were sensitive to first-line anti-TB drugs (40%), MDR in 25% of cases have been established.

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-28426</cfResPublId>
<cfResPublDate>2013-05-01</cfResPublDate>
<cfVol>14</cfVol>
<cfIssue>3</cfIssue>
<cfStartPage>391</cfStartPage>
<cfISSN>1857-1719</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/28426</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Caracteristica cazurilor cu recidivă de tuberculoză pulmonare</cfTitle>
<cfAbstr cfLangCode='RO' cfTrans='o'>In stuidu au fost incluse 417 cazuri de recidivă a tuberculozei pulmonare, aflaţi la tratament în Spitalul Clinic Municipal de Ftiziopneumologie Chisinau în anii 2010-2012. În structura incidenței globale recidivele de TB pulmonară au constituit 21,5 la 100 000 populaţie în anul 2012 sau cu 4,6% mai mult decît in anul 2011. A predominat depistarea pasivă - 357(86%) cazuri. Printre formele clinice de TB predomină TB pulmonară infiltrativă - 254(51%). Factori cu risc sporit pentru îmbolnăvire au avut un impact decisiv în aparitia recidivelor, 213 (51%) bolnavi au fost din grupul de risc. Aproximativ 1/2 din bolnavii cu recidive de TB pulmonară au fost sensibili la preparatele antituberculoase de prima linie (40%), în 25 % cazuri a fost stabilită Multidrogrezistența.</cfAbstr>
<cfAbstr cfLangCode='EN' cfTrans='o'>In study have been included 417 cases of relapse of pulmonary tuberculosis, who were treated in clinical municipal hospital from Chisinau in 2010-2012. In the structure of the global incidence of pulmonary TB recurrences were 21.5 to 100 000 people in 2012, with 4.6% more than in 2011. The passive way of detection have been predominated - 357 (86%) cases. Among clinical forms of TB infiltrative pulmonary TB have been predominated - 254 (51%). Risk factors for the disease have had a decisive impact in the occurrence of relapses, 213 (51%) patients were with risk factors. About half of patients with relapses of pulmonary TB were sensitive to first-line anti-TB drugs (40%), MDR in 25% of cases have been established.</cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-11309</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-18327</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-24490</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-33010</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-11309</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11309-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
<cfFamilyNames>Kulcitkaia</cfFamilyNames>
<cfFirstNames>Stela</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-18327</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-18327-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
<cfFamilyNames>Вылк</cfFamilyNames>
<cfFirstNames>В.</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-24490</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-24490-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
<cfFamilyNames>Malik</cfFamilyNames>
<cfFirstNames>Alina</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-33010</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-33010-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
<cfFamilyNames>Demişcan</cfFamilyNames>
<cfFirstNames>Galina</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>